US Market Access: “Who Pays?” comes first! While the US market for medical technologies is the largest in the world, it is probably the most complex when it comes to the practical monetization of novel technologies. Even before: clinical validation plans are made, FDA trajectories are explored, or KOL recruited, the board (and in particular the CEO) of any entrepreneurial …
Make The U.S. Your Growth Playfield